Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared on X:
“Spot on talk by Xue-Yan Jiang immunotherapy as a double-edged sword.
While IO revolutionises cancer care, managing irAEs remains key.
We needed predictors, early clinical markers and dedicated clinical pathways.”
Other articles about immunotherapy on OncoDaily.
